D-0833-2020 Class I Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- February 19, 2020
- Initiation Date
- December 20, 2019
- Termination Date
- February 23, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.
Reason for Recall
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Distribution Pattern
Nationwide in the U.S. and Puerto Rico.
Code Information
Lot #: 331771, Exp. June 2021